Catalyst Wire Dossier Catalyst Wire Dossier

PA401

· ProtAffin Biotechnologie AG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PA401, covering 2013-09-23 to 2013-09-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1, First in Human Study to Investigate the Safety and Tolerability of PA401 [Phase 1]

See pricing